ESC Premium Access

Basic mechanisms of pulmonary disease

Event: ESC CONGRESS 2019
Topic: Pathophysiology and Mechanisms
Session type: Moderated Posters
Date: 3 September 2019
Time: 15:45 - 16:35

Congress Session

7 presentations in this session

Cardiovascular coupling and elastic properties of pulmonary artery in different phenotypes of patients with pulmonary hypertension

Speaker: Doctor I. Lyapina (Kemerovo, RU)

Inhibin Beta-A is a novel gene involved in the development of pulmonary arterial hypertension through inhibiting BMPRII-signaling in endothelial cells

Speaker: Doctor G. Ryanto (Kobe, JP)

Poor outcomes in pulmonary arterial hypertension as a member of RNF213-associated vascular diseases

Speaker: Doctor T. Hiraide (Tokyo, JP)

Deficiency in milk fat globule-epidermal growth factor 8 delays thrombus resolution

Speaker: Doctor T. Hofbauer (Vienna, AT)

NKX2-5 contributes to EndoMT and endothelial dysfunction in pulmonary arterial hypertension

Speaker: Mr J. Santos Cade (London, GB)

Active selexipag metabolite MRE-269 increases endothelin receptors in pulmonary artery smooth muscle cells

Speaker: Doctor H. Maruyama (Tsuchiura, JP)

Evidence for ANTXR2 as a therapeutic target on systemic-to-pulmonary shunt induced pulmonary arterial hypertension

Speaker: Doctor X. Liu (Beijing, CN)

7 speakers from this session

Doctor Irina Lyapina

Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo (Russian Federation)
0 follower

Doctor Gusti Rizky Teguh Ryanto

Kobe University, Kobe (Japan)
0 follower

Doctor Takahiro Hiraide

Keio University School of Medicine, Tokyo (Japan)
0 follower

Doctor Thomas Hofbauer

Medical University of Vienna, Vienna (Austria)
0 follower

Mr Jamil Santos Cade

University College London, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

Doctor Hidekazu Maruyama

National Hospital Organization Kasumigaura Medical Center, Tsuchiura (Japan)
0 follower

Doctor Xiaoyan Liu

Beijing Chaoyang Hospital affiliated to Capital Medical University, Beijing (China)
0 follower

This platform is supported by

logo Novo Nordisk